The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for ''restricted emergency use'' on hospitalised...
from NDTV News - Latest https://www.ndtv.com/india-news/mylan-labs-to-manufacture-remdesivir-for-restricted-emergency-use-on-covid-19-patients-2256230
No comments:
Post a Comment